Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma

Technology appraisal guidance
Reference number: TA544
Published: 17 October 2018

History

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 260 KB)

Published:

17 September 2018
Committee papers (PDF 22.05 MB)

Published:

17 September 2018
Public committee slides - clinical (PDF 565 KB)

Published:

17 September 2018
Public committee slides - cost effectiveness (PDF 648 KB)

Published:

17 September 2018

Invitation to participate

Final scope (PDF 225 KB)

Published:

09 February 2018
Final matrix (PDF 261 KB)

Published:

09 February 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 335 KB)

Published:

09 February 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 317 KB)

Published:

09 October 2017
Draft matrix post referral (PDF 260 KB)

Published:

09 October 2017